SHARE
Pharmaceutical Drug Delivery Market

Pharmaceutical Drug Delivery Market Forecasts to 2028 – Global Analysis By Route of Administration (Injectable, Oral), Application (Cancer, Diabetes), End User (Hospitals, Diagnostic Centers) and By Geography

4.1 (98 reviews)
Published: July 2021 ID: SMRC20763
4.1 (98 reviews)
Published: July 2021 ID: SMRC20763

This report covers the impact of COVID-19 on this global market
Loading...

According to Stratistics MRC, the Global Pharmaceutical Drug Delivery Market is accounted for $1,430.50 billion in 2020 and is expected to reach $2,871.35 billion by 2028 growing at a CAGR of 9.1% during the forecast period. Factors such as rise in healthcare expenditure, growing concern and awareness about healthcare, and government support for research in the field of drug delivery are driving the growth of the market. However, risk of needlestick injuries is hampering the growth of the market.

A pharmaceutical drug delivery is a formulation or a device, which is employed for the administration of a therapeutic substance into the body. It functions by deploying medications to specifically targeted parts of the body by the aid of a medium, which can control the administration of the therapy by the means of either a physiological or chemical trigger. It is used to improve the efficacy and safety of an administered drug by controlling the rate, time, and site of release of drug in the body.

Based on the route of administration, the injectable drug delivery segment is anticipated to expand at a rapid pace during the forecast period owing to the increasing prevalence of chronic diseases, growing demand for biosimilar products, and low cost of devices. By geography, North America is going to have high growth during the forecast period which can be attributed to the increasing patient compliance to innovative drug delivery technologies and the presence of a large number of prominent players in this region.

Some of the key players profiled in the Pharmaceutical Drug Delivery Market include Teva Pharmaceuticals, Sanofi, Pfizer, Inc., Bristol-Myers Squibb, Novartis AG , Merck & Co., Inc., Becton, Amgen, F. Hoffman-La Roche, Eli Lilly and Company, Dickinson and Company, Antares Pharma, Inc, Boehringer Ingelheim, Johnson & Johnson, Inc., GlaxoSmithKline plc, Bayer AG, AstraZeneca, Genmab A/S, AbbVie, 3M Company, and Gilead Sciences, Inc.

Report Coverage

Details

Published Year:

2021

Estimated Market Size in 2020:

USD 1,430.50 billion

Estimated Period:

2020

Compound Annual Growth Rate (CAGR) from 2020 to 2028:

9.1%

Predicted 2028 Value:

USD 2,871.35 billion

Forecast Years:

2021-2028

Tables, Graphs& Figures

298

Chapters Covered:

Route of Administration, Application, End User and Region

Core Drivers and Opportunities:

  • Rise in healthcare expenditure
  • Growing concern and awareness about healthcare
  • Increasing demand for biosimilars

Restraining Factors & Market Threats:

  • Risk of needle stick injuries
  • Rising incidences of drug failures


Routes of Administration Covered:
• Injectable Drug Delivery
• Oral Drug Delivery
• Ocular Drug Delivery
• Topical Drug Delivery
• Nasal Drug Delivery
• Pulmonary Drug Delivery
• Implantable Drug Delivery
• Transmucosal Drug Delivery

Applications Covered:
• Cardiovascular Diseases
• Respiratory Diseases
• Cancer
• Infectious Diseases
• Diabetes
• Central Nervous System Disorders
• Autoimmune Diseases
• Other Applications    

End Users Covered:
• Hospitals
• Diagnostic Centers
• Ambulatory Surgery Centers/Clinics
• Home Care Settings 

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Key Questions Answered In The Report

The Global Pharmaceutical Drug Delivery Market is majorly driven by rise in healthcare expenditure, growing concern and awareness about healthcare, and government support for research in the field of drug delivery.

The injectable drug delivery segment is growing at a highest CAGR owing to the increasing prevalence of chronic diseases and growing demand for biosimilar products.

North America dominated with a significant market share due to the presence of a large number of prominent players in this region.

Asia Pacific market is growing at a highest CAGR owing to the rising awareness regarding the use of pharmaceutical drug delivery in the region.

Key players in Pharmaceutical Drug Delivery Market include Teva Pharmaceuticals, Sanofi, Pfizer, Inc., Bristol-Myers Squibb, Novartis AG , Merck & Co., Inc., Becton, Amgen, F. Hoffman-La Roche, Eli Lilly and Company, Dickinson and Company, Antares Pharma, Inc, Boehringer Ingelheim, Johnson & Johnson, Inc., GlaxoSmithKline plc, Bayer AG, AstraZeneca, Genmab A/S, AbbVie, 3M Company, and Gilead Sciences, Inc.

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials